Gene · 6892
TAPBP: TAP binding protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TAPBP: TAP binding protein. Genes, record 6892. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6892
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15533 | Tapasin | 448 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026174163 A1 | 2026-08-20 | 14 | O15533 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 66417 | O15533 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 66426 | O15533 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 12747 | O15533 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 14136 | O15533 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 13020 | O15533 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 14136 | O15533 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12747 | O15533 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 13020 | O15533 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 13020 | O15533 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,139
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TAPBP papers | Newest fiscal year |
|---|---|---|---|
| R01AI044115 | Influences of HLA Class I Polymorphisms on immune responses | 22 | 2025 |
| T32CA009476 | Cancer Biology Training Program | 14 | 2025 |
| R35GM125034 | An integrative structural biology approach to understanding metabolite recognition by cellular receptors | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 8 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 8 | 2025 |
| ZIAAI000394 | Molecular Genetic Analysis Of Lymphocyte Function | 8 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 7 | 2025 |
| P50CA097190 | Head and Neck Cancer SPORE | 7 | 2025 |
1 to 10 of 1,139Source NIH's project files
See all 1,139 nih grantsPapers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic states of an MHC class I molecule during peptide exchange. | Nat Commun | 2026 | 42722689 | PubTator, text mining | PubMed |
| Proximity-guided graph learning reveals tumour-associated proximity antigens. | Nature | 2026 | 42717092 | PubTator, text mining | PubMed |
| Reconstitution of glycan-driven MHC-I recycling reveals calreticulin as mediator between TAPBPR and tapasin. | EMBO J | 2026 | 42608479 | PubTator, text mining | PubMed |
| Integrating Multi-Omics and Mendelian Randomization Reveals the Role of Epstein-Barr Virus Infection in Alzheimer's Disease and the Therapeutic Potential of Resveratrol. | Curr Alzheimer Res | 2026 | 42509698 | PubTator, text mining | PubMed |
| Peptide Loading Complex in Cancer: From Peptide Translocation, Editing, and Loading into MHC-I to a Potential Therapeutic Target. | Curr Med Sci | 2026 | 42507253 | PubTator, text mining | PubMed |
Spatial Transcriptomics of Immune Cell Distribution in Non-Small Cell Lung Cancer Identifies Tertiary Lymphoid Structures and Its Density and Area Fraction Were Associated with Neoadjuvant Therapy Response. | Cancers (Basel) | 2026 | 42449683 | PubTator, text mining | PubMed |
| Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations. | Front Immunol | 2026 | 42273700 | PubTator, text mining | PubMed |
| NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects. | Mol Cancer | 2026 | 42210261 | PubTator, text mining | PubMed |
| CircSPECC1 attenuates sensitivity to PD-1 blockade through impaired antigen presentation in hepatocellular carcinoma. | Cancer Lett | 2026 | 42097490 | PubTator, text mining | PubMed |
| MSTN and TCF12 as Candidate Immunometabolic Signatures in Glioma-Associated Foam Cells: Insights from Integrated Multi-Omics Analysis. | Curr Issues Mol Biol | 2026 | 41899441 | PubTator, text mining | PubMed |
1 to 10 of 1,693
See all 1,693 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6892
GET https://conductscience.org/api/genes/v1/6892/patents?page=2